Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award

Recently, the Guangdong High-tech Association granted the certificates of “Guangdong Prominent High-tech Products” for 2023...

The Group featured in “Top100 Chinese Chemical Pharmaceutical Companies Ranking”, with its product winning award again

The 2024 China Medical and Health Industry Symbiosis Conference, organized by Menet, a healthcare information platform, was grandly held in Huzhou...

The Group’s in-house developed product Adapalene and Clindamycin Hydrochloride Gel was successfully launched

May 30, 2024, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) grandly held the launch ceremony at...

The Group’s in-licensed products INOmax® and INOmax DSIR Plus were successfully launched

Recently, the "Symposium on the Progress of Nitric Oxide Inhalation Therapy in Newborns" organized by the Shanghai Caritas Foundation...

Lee’s Pharmaceutical participated in the 88th PharmChina

May 15, 2024, the high-profile 88th PharmChina was grandly opened at the Shanghai National Exhibition and Convention Center...

Zhaoke-Hefei was honored with the “Safe Enterprise” title in Hefei for the year 2023

Recently, the Hefei Municipal Department of Economy and Information Technology announced the list of “Safe Enterprises”...
© Copyright - Lee's Pharmaceutical Holdings Limited.
- design by Morcept